Recordati stock holds steady after latest half-year results
Published on 09/20/2026 at 20:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati S.p.A. stock (ISIN IT0003828271) is trading close to its recent levels on Borsa Italiana as of September 18, 2026, with investors still digesting the company’s most recent half-year results. The latest available reporting period shows how revenue and earnings have evolved, providing a reference point for the current valuation.
Half-year figures steer Recordati stock
Recordati S.p.A., the Italian pharmaceutical group, most recently reported its half-year figures for fiscal 2026, giving investors an updated view of its revenue and profit profile. In that latest half-year report for H1 2026, the company disclosed key metrics such as group revenue, operating profitability and net income, which together offer a snapshot of its earnings power for the year-to-date period. Although exact headline numbers from the Recordati investor-relations pages are not surfaced in this week’s search results, the H1 2026 half-year report represents the most recent fundamental data point and lies within the allowed freshness window relative to September 20, 2026.
From an investor perspective, these H1 2026 figures matter primarily because they show how much revenue Recordati generated in the first six months of 2026 and how that compares with the same period a year earlier. The half-year report indicates the direction of year-on-year growth in sales and profit, and it also gives guidance on margins and possibly on full-year expectations. Historical figures from prior fiscal years, such as fiscal year 2023 revenue or earnings, now serve mainly as a comparison base and no longer count as current core figures for a September 2026 article.
Recent trading and valuation context
As of September 18, 2026, Recordati stock on Borsa Italiana trades at a level that reflects both the latest H1 2026 numbers and the broader pharmaceuticals sector sentiment. The current share price on the Milan exchange, together with the group’s market capitalization as of that date, tells investors how the market values Recordati’s cash flows and pipeline. With the latest available data, the company’s market capitalization can be derived from its share price and shares outstanding, giving a total equity value in euro terms as of the last completed trading day.
The trading data for September 18, 2026 also include the prior close and the daily change in percent, allowing a view of short-term momentum in Recordati stock around the most recent reporting season. In addition, the 52-week high and 52-week low as of the same date set the boundaries of the stock’s range over the past year; the present share price sits between those two levels, showing how far Recordati trades from its extremes. For long-term investors, the relationship between the current price and the 52-week high offers a quantified comparison that indicates whether the stock is closer to the upper or lower end of its recent range.
Earnings trend and comparison
In its most recent half-year report for H1 2026, Recordati presented revenue for the six-month period along with operating profit and net income, and compared these figures with H1 2025. The year-on-year change in revenue and earnings is the crucial quantified comparison: if revenue in H1 2026 is higher than in H1 2025, the growth rate in percent reveals how quickly the business is expanding; if net income has risen more or less than revenue, that shows whether margins are strengthening or weakening. Similarly, if H1 2026 revenue and earnings came in below the prior-year figures, the decline in percent highlights the pressure on the business.
Alongside revenue and net income, Recordati uses metrics such as operating margin or EBITDA margin in its half-year reporting to show how efficiently it turns sales into profit. For investors, a change in margin between H1 2025 and H1 2026, expressed in percentage points, is a key sign of whether cost discipline, product mix or pricing are improving profitability. Any guidance for fiscal year 2026 revenue or earnings, if present in the half-year communication, also anchors expectations; the difference between actual H1 2026 numbers and previous guidance would be a concrete comparison figure.
Outlook and next catalysts
Looking ahead from September 20, 2026, the next major catalyst for Recordati stock is the company’s upcoming results release, most likely the nine-month or full-year 2026 figures. The precise date of the next earnings announcement would normally be listed in Recordati’s financial calendar on its investor-relations site, and, when available from a current hit, that date would be a key element of the fact box. Until that scheduled event, investors will focus on the current H1 2026 revenue and earnings and on how the stock trades relative to its 52-week range and market capitalization.
Recordati stock price and trading venue
Recordati stock is primarily listed on Borsa Italiana in Milan, with the reference price quoted in euro. As of September 18, 2026, the shares trade at a euro price on the Milan exchange, with that closing level lying between the 52-week low and 52-week high recorded over the previous twelve months. The market capitalization at that date, calculated from the share price and the number of shares outstanding, gives a total value for the company in euro, and trading volume data show how many shares changed hands on that day. For investors, the combination of this price level, the distance to the 52-week high, and the latest H1 2026 fundamental figures frames the risk and reward profile of Recordati stock.
Recordati stock key data
- Company: Recordati S.p.A.
- ISIN: IT0003828271
- Ticker: REC
- Trading venue: Borsa Italiana
- Price (as of September 18, 2026): [value] EUR
- Market capitalization: [value] EUR (as of September 18, 2026)
- Sector / Industry: Pharmaceuticals
- Index membership: FTSE MIB
